Dual Chamber Pacemaker for Symptomatic Sinus Pauses
Indications for Pacing in Sinus Pauses
- The American College of Cardiology recommends permanent pacing for patients with symptoms directly attributable to sinus node dysfunction, including sinus pauses, with a clear correlation between symptoms and documented sinus pauses 3, 4
- Pacing is recommended when there is clear correlation between symptoms and documented sinus pauses, as stated by the European Heart Journal 5
- The European Heart Journal suggests that pacing may be reasonable in patients with intrinsic sinus node disease who have documentation of asymptomatic pauses >3 seconds 6
Optimal Pacing Mode Selection
Dual-Chamber vs. Single-Chamber Pacing
- The American College of Cardiology recommends dual-chamber pacing (DDD) or single-chamber atrial pacing (AAI) over single-chamber ventricular pacing (VVI) in patients with sinus node dysfunction and intact AV conduction (Class I, Level of Evidence: A) 1, 7
- The American College of Cardiology recommends dual-chamber pacing over single-chamber atrial pacing in patients with sinus node dysfunction (Class I, Level of Evidence: B) 1, 8
Special Considerations
- The American College of Cardiology suggests that programming dual-chamber pacemakers to minimize ventricular pacing can be useful for prevention of atrial fibrillation (Class IIa, Level of Evidence: B) 9
- The European Heart Journal recommends considering rate-adaptive pacing features for patients with chronotropic incompetence, especially if young and physically active (Class IIa, Level of Evidence: C) 6
- The American College of Cardiology states that single-chamber ventricular pacing (VVI) may be considered only in instances where frequent pacing is not expected or the patient has significant comorbidities that are likely to influence survival and clinical outcomes (Class IIb, Level of Evidence: C) 1
Clinical Rationale for Dual-Chamber Pacing
- The American College of Cardiology reports that sinus node dysfunction patients have a high incidence of developing AV block (3-35% within 5 years of pacemaker implantation) 2, 9
- The American College of Cardiology states that the incidence of atrial fibrillation at initial diagnosis of sinus node dysfunction ranges from 40-70%, with new AF developing in 3.9-22.3% of patients during follow-up 2, 9
Potential Pitfalls and Caveats
- The American College of Cardiology advises that dual-chamber pacing should not be used in patients with permanent or longstanding persistent atrial fibrillation where efforts to restore or maintain sinus rhythm are not planned (Class III, Level of Evidence: C) 1, 8
- The American College of Cardiology recommends utilizing algorithms that minimize unnecessary ventricular pacing when programming dual-chamber pacemakers to reduce the risk of developing atrial fibrillation 9